Children’s Hospital Colorado Center for Cancer and Blood Disorders (CCBD) Clinical Program occupies the entire 7th floor of the 294-bed Children’s Hospital Colorado. Facilities include a dedicated 24-bed inpatient unit with adjacent outpatient clinic and infusion center. There are approximately 1,063 CCBD inpatient hospital admissions per year and 18,234 outpatient visits. The CCBD includes approximately 30 MD faculty members and is divided into several distinct programs.
The Pediatric Oncology Program provides care to children, adolescents, and young adults with cancer. We have dedicated subspecialty Pediatric Neuro-Oncology (brain tumor) and Orthopedic Oncology (bone tumor) Programs. The CCBD Experimental Therapeutics Program was established to promote the development and clinical testing of promising new therapies for the treatment of children, adolescents, and young adults with cancer that have not responded well to available treatments or inadequate curative options. We also have an emphasis on survivorship that includes the H.O.P.E. (Helping Oncology Patients Excel) long-term follow-up clinic and TACTIC (Thriving After Cancer Treatment is Complete) clinic for adult cancer survivors.
The Pediatric Bone Marrow Transplant (BMT) Program at Children's Hospital Colorado was established in 1993. Since that time, the Program has performed over 600 transplants and their efforts have helped to shape the growing role of BMT in treating a variety of serious pediatric disorders. Diseases in which BMT can be used to provide curative treatment range from pediatric cancers to nonmalignant diseases of blood production such as aplastic anemia, thalessemia and sickle cell anemia to inherited defects of the immune system as well as to certain genetic disorders of metabolism such as Hurler's syndrome. The Program carries out transplants of hematopoietic (blood forming) stem cells from both autologous (self) and allogeneic (donated; related or unrelated) sources. Technologies in place utilize blood forming stem cells derived from marrow, peripheral blood and cord blood. A selection of innovative clinical trials aimed at improving transplant outcomes and expanding diseases that may be helped with BMT are available to patients who wish to participate.
The Pediatric Hematology Program is responsible for the care of patients with primary noncancerous blood disorders, including hemophilia, coagulation disorders that produce excess bleeding or clotting, sickle cell anemia, thalassemia, and a variety of other hematologic disorders. Major clinical components include the regional Hemophilia Center and state-funded Sickle Cell Anemia Center. The Immuno-Hematology Clinic focuses on disorders of white blood cell function and how the immune system influences blood cell number and function.
Our faculty and staff are also involved with many support programs, including the HOPE Survivorship Program (Helping Oncology Patients Excel), YAPS (Youth and Pet Survivors Program), Teen and Young Adults support program, Sickle Cell Camp, Hemophilia Camp, Butterfly Program, Wilderness Program and Robbie's Friends. These programs provide the Hematology, Oncology and Bone Marrow Transplantation patients and their families with support through camping program events and peer interaction. The faculty and staff involvement ranges from an advisory role to staffing of the various camps.